title: Imatinib-associated pulmonary alveolar proteinosis.
authors.forename: Ulrich
authors.initials: U
authors.lastname: Wagner
authors.forename: Petra
authors.initials: P
authors.lastname: Staats
authors.forename: Roland
authors.initials: R
authors.lastname: Moll
authors.forename: Ulrich
authors.initials: U
authors.lastname: Feek
authors.forename: Claus
authors.initials: C
authors.lastname: Vogelmeier
authors.forename: David A
authors.initials: DA
authors.lastname: Groneberg
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D010879:Piperazines / Q000009:adverse effects*; D011649:Pulmonary Alveolar Proteinosis / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D011743:Pyrimidines / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate